Symptom Management for Irritable Bowel Syndrome

Not Applicable

Completed

• Conditions: Irritable Bowel Syndrome

• Registration Number: NCT02079857
• Lead Sponsor: NYU Langone Health

Brief Summary

The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-11
• Study First Submitted: 2014-03-03
• Study First Submitted QC: 2014-03-04
• Study First Posted: 2014-03-06
• Primary Completion: 2019-11-01
• Study Completion: 2019-11-01
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-27
• Last Update Posted: 2020-07-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 183

Inclusion Criteria

• Men and women 18 to 70 years of age.
• Diagnosis of IBS based on ROME III criteria.
• Complete symptom diaries and return completed diaries at all sessions.

Exclusion Criteria

• History of co-existing gastrointestinal, and/or gynecological, and/or urologic pathology.
• Alarm symptoms according to ROME III.
• Individuals currently receiving other types of complementary therapies.
• Individuals with an acute medical condition requiring acute medical attention.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Symptom severity-abdominal pain	week 24

Trial Locations

Locations (1)

NYU Division of Special Studies in Symptom Management; 🇺🇸 New York, New York, United States